A federal jury in California has ruled that Apple Inc. (NASDAQ: AAPL) must pay Masimo Corporation (NASDAQ: MASI) $634 million for infringing a patent related to blood-oxygen reading technology. The ...

Apple removed blood oxygen monitoring from the Apple Watch in early 2024. Somebody has to blink for it to return, and it looks like neither Masimo nor Apple are going to budge. Blood oxygen monitoring ...

Apple is now planning to appeal an infamous ban that led to the Apple Watch Series 9 and Ultra 2 versions losing the blood oxygen sensor feature last year in court. The case saw the International ...

The Index is a $170 armband that can track your sleep so you don’t have to wear a watch to bed. Beth Skwarecki is Lifehacker’s Senior Health Editor, and holds certifications as a personal trainer and ...

Yasmine Crossland is an experienced technology journalist who has covered everything from smartphones and tablets to true wireless earbuds and soundbars. She has written for titles such as Pocket-Lint ...

Forget the so-called 'Pulsed-Field Ablation Wars'—competition in the continuous glucose monitor (CGM) market is just as fierce. There have been several key approvals in the space, and on Monday, ...

Masimo has now won decisive victories against Apple with both the ITC and a juried trial, which may be enough to get Apple executives to rethink its current legal strategy. Separately, Masimo's CEO ...

Embattled Masimo Corp. founder Joe Kiani, who was ousted as chairman, resigned as chief executive last week—making good on his promise to exit the company if he lost the proxy battle against activist ...

Masimo announced that its CEO Joe Kiani informed the board of directors that he has stepped down from his post. He was replaced by board member Michelle Brennan on an interim basis. The change is ...